Detalles de la búsqueda
1.
Both radiographical and pathological lymph node statuses are independent predictors for survival following neoadjuvant chemotherapy and radical cystectomy for cT3/4 or cN+ bladder cancer.
World J Urol
; 41(1): 101-107, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36269368
2.
Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study.
Acta Oncol
; 61(1): 52-57, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34736367
3.
Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice.
J Urol
; 206(2): 240-251, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33835866
4.
Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II Instrument.
Urol Int
; 105(1-2): 31-40, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32829338
5.
Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT).
BMC Cancer
; 20(1): 8, 2020 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31900121
6.
Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
Future Oncol
; 16(29): 2307-2328, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32964728
7.
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
Lancet
; 391(10122): 748-757, 2018 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29268948
8.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Lancet
; 389(10064): 67-76, 2017 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27939400
9.
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 18(3): 312-322, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28131785
10.
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Lancet
; 387(10031): 1909-20, 2016 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26952546
11.
Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapy.
BJU Int
; 119(1): 30-37, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27037533
12.
A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer.
Prostate
; 76(13): 1160-8, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27198487
13.
CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1.
J Urol
; 195(3): 771-9, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26318986
14.
Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer.
J Urol
; 196(2): 382-91, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26964917
15.
Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer.
Eur J Nucl Med Mol Imaging
; 43(12): 2114-2121, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27290607
16.
Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer.
Eur J Nucl Med Mol Imaging
; 43(12): 2105-2113, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27317482
17.
Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival.
World J Urol
; 34(4): 569-76, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26260193
18.
A robust blood gene expression-based prognostic model for castration-resistant prostate cancer.
BMC Med
; 13: 201, 2015 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-26297150
19.
Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09).
Oncology
; 89(2): 70-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25765871
20.
Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experience.
BMC Cancer
; 15: 455, 2015 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26040470